XOMA Co. (NASDAQ:XOMAO) Sees Significant Drop in Short Interest

XOMA Co. (NASDAQ:XOMAO) saw a significant decrease in short interest during the month of December. As of December 31st, there was short interest totaling 9,148 shares, a decrease of 21.2% from the December 15th total of 11,615 shares. Based on an average daily volume of 2,126 shares, the days-to-cover ratio is presently 4.3 days. Based on an average daily volume of 2,126 shares, the days-to-cover ratio is presently 4.3 days.

XOMA Price Performance

NASDAQ XOMAO traded down $0.03 during trading hours on Friday, hitting $25.32. The company had a trading volume of 1,577 shares, compared to its average volume of 4,025. XOMA has a fifty-two week low of $23.32 and a fifty-two week high of $25.76. The business has a fifty day simple moving average of $25.42 and a 200-day simple moving average of $25.44.

About XOMA

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.